|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate investments: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings, equipment and improvements | ||||||||||||||||||||
| Total real estate investments | ||||||||||||||||||||
| Less: accumulated depreciation | ||||||||||||||||||||
| Total real estate investments, net | ||||||||||||||||||||
| Intangible real estate assets, net | ||||||||||||||||||||
| Total real estate investments and intangible real estate assets, net | ||||||||||||||||||||
| Real estate held for sale | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Straight-line rent adjustment | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Long-term debt, net of deferred financing costs | ||||||||||||||||||||
| Term loan and revolving credit facility, net of deferred financing costs | ||||||||||||||||||||
| Senior unsecured notes, net of deferred financing costs | ||||||||||||||||||||
| Total long-term debt, net of deferred financing costs | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Rent received in advance | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred stock, par value 0.0001 per share; 25,000,000 authorized, zero shares issued and outstanding | ||||||||||||||||||||
| Common stock, par value 0.0001 per share; 500,000,000 shares authorized, 90,565,195 and 85,637,293 shares issued and outstanding, respectively | ||||||||||||||||||||
| Preferred stock, $0.0001 par value per share, 25,000,000 shares authorized, zero shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.0001 par value per share, 500,000,000 shares authorized, 109,756,406 and 108,188,605 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total Liabilities and Equity |
Loading...
